ArticleRSC advances2023

Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation.

Sunil Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.